These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35877697)

  • 61. Norepinephrine may promote the progression of
    Du X; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Hu Q; Tian Q; Liang L; Zhao X; Li J; Zhao M; Fu X
    Virulence; 2024 Dec; 15(1):2350904. PubMed ID: 38725098
    [No Abstract]   [Full Text] [Related]  

  • 62. Genetic Transformation of Fusobacterium nucleatum.
    Yoshida A; Ikegami A
    Methods Mol Biol; 2021; 2210():43-50. PubMed ID: 32815126
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis.
    Villar-Ortega P; Expósito-Ruiz M; Gutiérrez-Soto M; Ruiz-Cabello Jiménez M; Navarro-Marí JM; Gutiérrez-Fernández J
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 May; 40(5):224-234. PubMed ID: 35256335
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development.
    Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X
    Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fusobacterium nucleatum - Friend or foe?
    Stokowa-Sołtys K; Wojtkowiak K; Jagiełło K
    J Inorg Biochem; 2021 Nov; 224():111586. PubMed ID: 34425476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
    Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
    Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis.
    Sakamoto Y; Mima K; Ishimoto T; Ogata Y; Imai K; Miyamoto Y; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Komohara Y; Ogino S; Baba H
    Cancer Sci; 2021 Nov; 112(11):4470-4477. PubMed ID: 34464993
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discovery of potent natural product higenamine derivatives as novel Anti-Fusobacterium nucleatum agents.
    Su S; Bu Q; Bai X; Huang Y; Wang F; Hong J; Fang JY; Wu S; Sheng C
    Bioorg Chem; 2023 Sep; 138():106586. PubMed ID: 37178651
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
    Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
    Park JA; Lee GR; Lee JY; Jin BH
    Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Strain-level detection of
    Shimomura Y; Sugi Y; Kume A; Tanaka W; Yoshihara T; Matsuura T; Komiya Y; Ogata Y; Suda W; Hattori M; Higurashi T; Nakajima A; Matsumoto M
    Microbiol Spectr; 2023 Dec; 11(6):e0512322. PubMed ID: 37819098
    [No Abstract]   [Full Text] [Related]  

  • 72. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
    Ito M; Kanno S; Nosho K; Sukawa Y; Mitsuhashi K; Kurihara H; Igarashi H; Takahashi T; Tachibana M; Takahashi H; Yoshii S; Takenouchi T; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2015 Sep; 137(6):1258-68. PubMed ID: 25703934
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
    Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
    J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Tagg JR
    Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of oral microbiome in pemphigus vulgaris.
    Zorba M; Melidou A; Patsatsi A; Poulopoulos A; Gioula G; Kolokotronis A; Minti F
    Arch Microbiol; 2021 Jul; 203(5):2237-2247. PubMed ID: 33634320
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
    Leung A; Tsoi H; Yu J
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of the Progression of Fusobacterium nucleatum-induced Apical Periodontitis on the Gut Microbiota.
    Haraga H; Sato T; Watanabe K; Hamada N; Tani-Ishii N
    J Endod; 2022 Aug; 48(8):1038-1045. PubMed ID: 35545147
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of
    Guven DC; Dizdar O; Alp A; Akdoğan Kittana FN; Karakoc D; Hamaloglu E; Lacin S; Karakas Y; Kilickap S; Hayran M; Yalcin S
    Biomark Med; 2019 Jun; 13(9):725-735. PubMed ID: 31157977
    [No Abstract]   [Full Text] [Related]  

  • 79. Fusobacterium nucleatum detected simultaneously in a pyogenic liver abscess and advanced sigmoid colon cancer.
    Shigefuku R; Watanabe T; Kanno Y; Ikeda H; Nakano H; Hattori N; Matsunaga K; Matsumoto N; Kanno SI; Nosho K; Hachiya A; Iwatani Y; Matsumori T; Tsukikawa S; Makizumi R; Otsubo T; Yamamoto H; Itoh F
    Anaerobe; 2017 Dec; 48():144-146. PubMed ID: 28823592
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
    Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X
    Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.